EBC is a network of key players in the “Brain Area”, with a membership encompassing scientific societies, patient organisations, professional societies and industry partners.
10 11-2022

Launch event of the RETHINKING Alzheimer’s disease White Paper

2023-01-11T08:46:20+00:0010-11-2022|

The launch event of the RETHINKING Alzheimer’s disease White Paper, calling for change in Alzheimer’s care, will take place virtually on 24 January 2023 at 12:30 – 14:00. The European Brain Council (EBC), in collaboration with the European Federation of Pharmaceutical Industries and Associations (EFPIA), will present its White Paper “RETHINKING Alzheimer’s disease: Detection and diagnosis“. This paper is [...]

19 05-2021

IMI PARADIGM develops toolkit to make patient engagement in medicines development easier for all

2021-05-20T11:55:20+00:0019-05-2021|News|

There is consensus among stakeholders that patient engagement at different points of the medicines lifecycle is critical to fostering patient access to innovative therapeutic solutions, and delivering better health outcomes for patients.  IMI PARADIGM, a public private consortium consisting of patients, academia, industry, HTA bodies and regulators, developed a toolkit to make patient engagement [...]

17 05-2021

Registration for the Value of Treatment 2 Synthesis Meeting open!

2021-05-18T07:35:14+00:0017-05-2021|News|

The European Brain Council is pleased to invite you to join us for the upcoming Value of Treatment for Brain Disorders Research Project “Case studies on Rare Diseases and Mental Disorders” Virtual Synthesis Meeting to be held on 8 June 2021 at 13:00-17:30. The Value of Treatment (VOT) is a health economics and outcomes research project addressing all brain disorders, conceptualized in 2015 by the [...]

Go to Top